EnzyMed

As of October 20, 1999, Enzymed, Inc. was acquired by Albany Molecular Research Inc. Enzymed Inc. focuses on the discovery, optimization, and identification of pharmaceutical and agrochemical compounds produced through combinatorial biocatalysis. The company's proprietary technology utilizes iterative enzymatic and microbial reactions along with selected chemical synthesis to create libraries of diverse compounds suitable for small molecules and complex natural products. Enzymed was founded in 1994 and is headquartered in Iowa City, Iowa.